Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

NCT03547908 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1/HBV Co-Infection

Interventions

DRUG: B/F/TAF
DRUG: Placebo to match DTG
DRUG: Placebo to match F/TDF
DRUG: DTG
DRUG: F/TDF
DRUG: Placebo to match B/F/TAF

Sponsor

Gilead Sciences